Existing cancer drug may protect the heart during certain chemotherapy treatments
The chemotherapy agent doxorubicin is used successfully to treat a range of cancers but can, as a side effect, damage the heart muscle. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have now identified the molecular signaling pathway through which doxorubicin causes cardiac injury. They also discovered that SAHA (suberoylanilide hydroxamic acid), a drug already…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
